Table 4.
GRADE assessment for outcomes reported in RCTs on collagen vs. standard of care for chronic wounds.
Outcomes | No. of studies | Study design | Risk of bias | Inconsistency | Indirectness | Imprecision | Other considerations | No. of patients |
Relative effect (95% CI) | Certaintya | |
---|---|---|---|---|---|---|---|---|---|---|---|
Collagen | SOC | ||||||||||
Wound healing rate | 11 | RCT | Seriousb | No | No | No | No | 484 | 473 | RR = 1.53 (1.33, 1.77) | ⊕⊕⊕○ Moderate |
Healing velocity | 2 | RCT | No | No | No | No | No | 171 | 166 | MD = 2.69 (0.87, 4.51) | ⊕⊕⊕⊕ High |
Recurrence of ulceration | 3 | RCT | No | Seriousc | No | No | No | 114 | 53 | RR = 0.47 (0.27, 0.79) | ⊕⊕⊕○ Moderate |
Adverse events | 7 | RCT | No | No | No | No | No | 281 | 274 | RR = 0.67 (0.44, 1.01) | ⊕⊕⊕⊕ High |
RCT, randomized controlled trial; MD, mean difference; CI, confidence interval; RR, risk ratio; SOC, standard of care.
GRADE Working Group grades of evidence: High quality = we are very confident that the true effect lies close to that of the estimate of the effect.; Moderate quality = we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different; Low quality = our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect; Very low quality = we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect.
Downgraded one level for concerns with performance bias.
Downgraded one level for I2 > 50%.